Boosting peptide half-life: enabling efficient generation of Fc-peptide conjugates.
Saved in:
| Title: | Boosting peptide half-life: enabling efficient generation of Fc-peptide conjugates. |
|---|---|
| Authors: | Park M; Yusuf Hamied Department of Chemistry, University of Cambridge Cambridge UK spring@ch.cam.ac.uk., Dannheim FM; Yusuf Hamied Department of Chemistry, University of Cambridge Cambridge UK spring@ch.cam.ac.uk., Papworth MA; Oncology R&D, AstraZeneca UK., Kay R; Institute of Metabolic Science, Department of Clinical Biochemistry, University of Cambridge UK., Tsonou E; BioPharmaceuticals R&D, AstraZeneca UK., Trajkovski D; Department of Surgery, University of Cambridge UK., Walsh SJ; Yusuf Hamied Department of Chemistry, University of Cambridge Cambridge UK spring@ch.cam.ac.uk., Hovdal D; Preclinical and Translational PK & PKPD Specialist (DMPK), AstraZeneca Gothenburg Sweden., Wharton T; Yusuf Hamied Department of Chemistry, University of Cambridge Cambridge UK spring@ch.cam.ac.uk., Nassoy AC; Oncology R&D, AstraZeneca UK., Parker JS; Early Chemical Development, Pharmaceutical Development, R&D, AstraZeneca Macclesfield UK., Spring DR; Yusuf Hamied Department of Chemistry, University of Cambridge Cambridge UK spring@ch.cam.ac.uk. |
| Source: | Chemical science [Chem Sci] 2026 May 29; Vol. 17 (27), pp. 13454-13464. Date of Electronic Publication: 2026 May 29 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Royal Society of Chemistry Country of Publication: England NLM ID: 101545951 Publication Model: eCollection Cited Medium: Print ISSN: 2041-6520 (Print) Linking ISSN: 20416520 NLM ISO Abbreviation: Chem Sci Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42266899 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Boosting peptide half-life: enabling efficient generation of Fc-peptide conjugates. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Park+M%22">Park M</searchLink>; Yusuf Hamied Department of Chemistry, University of Cambridge Cambridge UK spring@ch.cam.ac.uk.<br /><searchLink fieldCode="AU" term="%22Dannheim+FM%22">Dannheim FM</searchLink>; Yusuf Hamied Department of Chemistry, University of Cambridge Cambridge UK spring@ch.cam.ac.uk.<br /><searchLink fieldCode="AU" term="%22Papworth+MA%22">Papworth MA</searchLink>; Oncology R&D, AstraZeneca UK.<br /><searchLink fieldCode="AU" term="%22Kay+R%22">Kay R</searchLink>; Institute of Metabolic Science, Department of Clinical Biochemistry, University of Cambridge UK.<br /><searchLink fieldCode="AU" term="%22Tsonou+E%22">Tsonou E</searchLink>; BioPharmaceuticals R&D, AstraZeneca UK.<br /><searchLink fieldCode="AU" term="%22Trajkovski+D%22">Trajkovski D</searchLink>; Department of Surgery, University of Cambridge UK.<br /><searchLink fieldCode="AU" term="%22Walsh+SJ%22">Walsh SJ</searchLink>; Yusuf Hamied Department of Chemistry, University of Cambridge Cambridge UK spring@ch.cam.ac.uk.<br /><searchLink fieldCode="AU" term="%22Hovdal+D%22">Hovdal D</searchLink>; Preclinical and Translational PK & PKPD Specialist (DMPK), AstraZeneca Gothenburg Sweden.<br /><searchLink fieldCode="AU" term="%22Wharton+T%22">Wharton T</searchLink>; Yusuf Hamied Department of Chemistry, University of Cambridge Cambridge UK spring@ch.cam.ac.uk.<br /><searchLink fieldCode="AU" term="%22Nassoy+AC%22">Nassoy AC</searchLink>; Oncology R&D, AstraZeneca UK.<br /><searchLink fieldCode="AU" term="%22Parker+JS%22">Parker JS</searchLink>; Early Chemical Development, Pharmaceutical Development, R&D, AstraZeneca Macclesfield UK.<br /><searchLink fieldCode="AU" term="%22Spring+DR%22">Spring DR</searchLink>; Yusuf Hamied Department of Chemistry, University of Cambridge Cambridge UK spring@ch.cam.ac.uk. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101545951%22">Chemical science</searchLink> [Chem Sci] 2026 May 29; Vol. 17 (27), pp. 13454-13464. <i>Date of Electronic Publication: </i>2026 May 29 (<i>Print Publication: </i>2026). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Royal+Society+of+Chemistry%22">Royal Society of Chemistry </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101545951 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2041-6520 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220416520%22">20416520 </searchLink><i>NLM ISO Abbreviation: </i>Chem Sci <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42266899 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1039/d6sc02646j Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 13454 Titles: – TitleFull: Boosting peptide half-life: enabling efficient generation of Fc-peptide conjugates. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Park M – PersonEntity: Name: NameFull: Dannheim FM – PersonEntity: Name: NameFull: Papworth MA – PersonEntity: Name: NameFull: Kay R – PersonEntity: Name: NameFull: Tsonou E – PersonEntity: Name: NameFull: Trajkovski D – PersonEntity: Name: NameFull: Walsh SJ – PersonEntity: Name: NameFull: Hovdal D – PersonEntity: Name: NameFull: Wharton T – PersonEntity: Name: NameFull: Nassoy AC – PersonEntity: Name: NameFull: Parker JS – PersonEntity: Name: NameFull: Spring DR IsPartOfRelationships: – BibEntity: Dates: – D: 29 M: 05 Text: 2026 May 29 Type: published Y: 2026 Identifiers: – Type: issn-print Value: 2041-6520 Numbering: – Type: volume Value: 17 – Type: issue Value: 27 Titles: – TitleFull: Chemical science Type: main |
| ResultId | 1 |
